Identity
Gonadorelin is GnRH; pulsatile delivery and intermittent self-injection are distinct treatment approaches.
Selected study only; not a complete clinical review.
Peptide library
Gonadorelin
Your guide to this compound.
Mechanism illustrationEnlarge
Evidence in perspective
The retrospective fertility cohort is relevant to supervised pulsatile GnRH in functional hypothalamic amenorrhea. Selection, specialist care and lack of a randomized comparator limit attribution; it is not evidence for generic hormone optimization.
About this assessment
Existing source snapshot critically reassessed.
Based on the selected source scope described in this profile, often an indexed abstract. Full methods and clinician sign-off remain pending; no systematic-review claim.
Editorial assessment · 2026-09-07
Who was studied
66 women with functional hypothalamic amenorrhea; retrospective fertility cohort.
What the sources found
A supervised GnRH pump was associated with ovulation and live births. The observational study does not validate general hormone optimization.
Regulatory scope
Current authorization for the exact product and jurisdiction was not independently checked in this snapshot. A clinical trial is not marketing authorization.
What remains unknown
Selected indexed primary-study abstract reviewed. Full methods, bias, all safety outcomes, product stability, current jurisdictional authorization and a comprehensive literature search remain outstanding. This is not a complete clinical review.
How it works
Gonadorelin is GnRH; pulsatile delivery and intermittent self-injection are distinct treatment approaches.
The study-specific findings below distinguish biological activity from demonstrated treatment benefit.
Human trials
This catalog identifies human research. A trial can be early, small or negative; its existence does not establish approval or benefit for every proposed use. Check the study population and outcomes.
Reported adverse effects
- One twin pregnancy was reported; comparative safety cannot be established from this cohort alone.
Selected study only; not a complete clinical review.
Contraindications
- A complete contraindication and interaction review remains outstanding.
Human trials
This catalog identifies human research. A trial can be early, small or negative; its existence does not establish approval or benefit for every proposed use. Check the study population and outcomes.
Sources used for this snapshot
Claim-by-claim evidence
Benefits
A supervised GnRH pump was associated with ovulation and live births. The observational study does not validate general hormone optimization.
Selected study only; not a complete clinical review.
Adverseeffects
One twin pregnancy was reported; comparative safety cannot be established from this cohort alone.
Selected study only; not a complete clinical review.
References
Use of pulsatile gonadotropin-releasing hormone (GnRH) in patients with functional hypothalamic amenorrhea (FHA) results in monofollicular ovulation and high cumulative live birth rates: a 25-year cohort. 2022.
PMID: 36378460
Catalog review date: Sep 7, 2026. This date alone does not establish independent clinical review.